Correlation Between Neurobo Pharmaceuticals and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and GT Biopharma, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and GT Biopharma.
Diversification Opportunities for Neurobo Pharmaceuticals and GT Biopharma
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neurobo and GTBP is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and GT Biopharma go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and GT Biopharma
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 1.28 times less return on investment than GT Biopharma. But when comparing it to its historical volatility, Neurobo Pharmaceuticals is 1.57 times less risky than GT Biopharma. It trades about 0.0 of its potential returns per unit of risk. GT Biopharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 850.00 in GT Biopharma on September 12, 2024 and sell it today you would lose (546.00) from holding GT Biopharma or give up 64.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. GT Biopharma
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| GT Biopharma |
Neurobo Pharmaceuticals and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and GT Biopharma
The main advantage of trading using opposite Neurobo Pharmaceuticals and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| GT Biopharma vs. Allarity Therapeutics | GT Biopharma vs. Neurobo Pharmaceuticals | GT Biopharma vs. Virax Biolabs Group | GT Biopharma vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |